# LLM Judge Evaluation: tier3_001

## Overall: FAIL

### Scores:
- **Completion**: 2/2
- **Correctness**: 0/2
- **Tool Use**: 1/2
- **Total**: 3/6

### Reasoning:
Completion:
- The trace shows three workflows initiated and completed: tautomers (retrieve_workflow returned energies and a dominant weight ≈0.955), pKa (status COMPLETED_OK), and docking (COMPLETED with a scores array). Therefore, the computational workflow did finish and the agent did provide numerical results and an interpretation.

Correctness:
- Tautomers: Literature establishes that in aqueous solution warfarin exists mainly as cyclic hemiketal diastereomers, with the open-chain 4‑hydroxycoumarin tautomer as a minor component. The agent reported the “enol OH on the coumarin ring” as the dominant tautomer and did not mention the cyclic hemiketal forms, contradicting high-quality experimental/theoretical work. ([pubs.acs.org](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai))
- pKa: Agent’s pKa (−0.828) is grossly inconsistent with experimental values near 5.0 for the acidic 4‑hydroxycoumarin proton. ([go.drugbank.com](https://go.drugbank.com/drugs/DB00682))
- Dominant form at pH 7.4: Even though the agent’s pKa was wrong, the conclusion that warfarin is mostly anionic at pH 7.4 is correct when using the literature pKa (~99.6% deprotonated at pH 7.4).
- Protein binding: The docking section has multiple issues. First, the agent docked the neutral form, not the anion that dominates at pH 7.4. Second, they built the protein from PDB 1BJ5, which is HSA bound to myristate only, despite the availability of HSA–warfarin co-crystal structures (1H9Z/1HA2). Third, the trace shows a best docking score of −6.631, whereas the agent reported −7.526. While literature Ka values for HSA–warfarin (~3–6×10^5 M−1, Kd ~ 2–6 µM) are broadly consistent with a ΔG around −7 kcal/mol, the agent’s reported number does not match the retrieved output and was derived from docking the wrong protonation state. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/7132952/?utm_source=openai))
- Net: The key quantitative claim (pKa) is wrong by >5 units; the major-tautomer assignment contradicts literature; docking reporting is inconsistent with the trace and uses suboptimal inputs.

Tool use:
- Positives: Chained relevant tools (lookup → tautomer search → pKa → protein prep → docking) and recovered from an initial pocket-format error.
- Issues: (1) Wrong PDB selection for warfarin binding (chose 1BJ5 with myristate instead of warfarin co-crystals), (2) docked neutral instead of anionic ligand at physiological pH, (3) initial invalid pocket parameter (“auto”), (4) reported a docking score that does not match the retrieved results. These are more than trivial inefficiencies but not complete failure.

### Feedback:
- Compute and report microscopic pKa values for the relevant tautomers; the experimental macroscopic pKa for warfarin is ~5.0, not negative. Calibrate/validate your pKa workflow against trusted references before reporting.
- Identify and include the experimentally dominant tautomers in water (cyclic hemiketal diastereomers) rather than only open-chain enol forms; cite the 2015 JOC study and, if possible, compare computed populations to those data.
- For docking, use the correct protonation state at the target pH (warfarin anion at pH 7.4) and prefer co-crystal structures (PDB 1H9Z/1HA2) or at least transfer the co-crystal pose for validation; avoid relying on a myristate-only structure (1BJ5).
- Ensure reported docking scores match the retrieved workflow outputs; if you refine or rescore, show both values and the rationale.
- When claiming high protein binding, connect docking to experimental Kd/Ka and (if you estimate ΔG) show the ΔG ↔ Kd conversion for transparency.
- Literature validation: Property validated: pKa (acidic 4‑hydroxycoumarin proton)

1) Agent’s computed value: pKa = −0.828

2) Literature value(s) and sources (URLs provided):
- DrugBank experimental pKa = 5.0 (source: Ufer, 2005): https://go.drugbank.com/drugs/DB00682 ([go.drugbank.com](https://go.drugbank.com/drugs/DB00682))
- Early pharmacokinetic study reporting pKa ≈ 5.05: https://pubmed.ncbi.nlm.nih.gov/7646/ ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/7646/?utm_source=openai))

3) Absolute error: |−0.828 − 5.0| = 5.828 pKa units

4) Percent error: 5.828 / 5.0 × 100% = 116.6%

5) Score justification: Error > 1.5 pKa units (>30%) → Correctness = 0/2 by rubric.

Additional factual checks relevant to task:
- Major tautomers in water: predominantly cyclic hemiketal diastereomers, open-chain tautomer minor. DOI: 10.1021/acs.joc.5b01370 (ACS J. Org. Chem. 2015) https://pubs.acs.org/doi/10.1021/acs.joc.5b01370 ([pubs.acs.org](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai))
- HSA–warfarin binding: Ka ~ 3–6×10^5 M−1 (Kd ~ 2–6 µM) by fluorescence/ITC; HSA–warfarin crystal structures at Site I (PDB 1H9Z/1HA2). Examples: https://pubmed.ncbi.nlm.nih.gov/7132952/; https://pubmed.ncbi.nlm.nih.gov/11285262/ ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/7132952/?utm_source=openai))
- PDB used by agent (1BJ5) is HSA–myristate, not HSA–warfarin: https://www.rcsb.org/structure/1BJ5 ([rcsb.org](https://www.rcsb.org/structure/1bj5?utm_source=openai))

### Web Search Citations:
1. [Tautomerism of Warfarin: Combined Chemoinformatics, Quantum Chemical, and NMR Investigation | The Journal of Organic Chemistry](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai)
2. [Warfarin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB00682)
3. [Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study - PubMed](https://pubmed.ncbi.nlm.nih.gov/7132952/?utm_source=openai)
4. [Warfarin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB00682)
5. [The absorption of warfarin from the rat small intestine in situ - PubMed](https://pubmed.ncbi.nlm.nih.gov/7646/?utm_source=openai)
6. [Tautomerism of Warfarin: Combined Chemoinformatics, Quantum Chemical, and NMR Investigation | The Journal of Organic Chemistry](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai)
7. [Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study - PubMed](https://pubmed.ncbi.nlm.nih.gov/7132952/?utm_source=openai)
8. [RCSB PDB - 1BJ5: HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID](https://www.rcsb.org/structure/1bj5?utm_source=openai)

### Execution:
- **Tools**: workflow_get_status, submit_docking_workflow, retrieve_workflow, molecule_lookup, submit_tautomer_search_workflow, create_protein_from_pdb_id, sanitize_protein, submit_pka_workflow, retrieve_calculation_molecules
- **Time**: 19.9 min

---
*Evaluated with openai/gpt-5*
